Cellexus Biosystems Achieves Significant Milestone
News May 22, 2006
Cellexus Biosystems PLC of Cambridgeshire, UK, has achieved a significant milestone when it unveiled its products to researchers attending the internationally renowned SCIpharm 2006 conference in Edinburgh this week.
Attendees at SCIpharm were given an exclusive preview of the company’s products, which will be used for the production of cells used in bioresearch and production of medicines by the biopharmaceutical industry.
On show were the CellMaker Lite™ 2-10 litre and the CellMaker Lite™ 10-50 litre versions of the system.
Cellexus claims that, the CellMaker™ Lite does not need to be shaken, stirred, rocked or rolled, which means that it is both simple to use and easy to manufacture.
Commenting on the exhibition, Dr Auton said, "SCIpharm was an excellent opportunity for us to preview our products to leaders in the pharmaceutical industry."
"The simplicity of our systems and their low investment costs generated a strong and positive reaction from researchers, who liked the design of the CellMaker Lite and its ease-of-use."
"All could immediately see the application of our technology in their own operational environments."
The Company expects to begin shipping production systems to customers in the fourth quarter of 2006.
Scientists have used machine learning to train computers to see parts of the cell the human eye cannot easily distinguish. Using 3D images of fluorescently labeled cells, the research team taught computers to find structures inside living cells without fluorescent labels, using only black and white images generated by an inexpensive technique known as brightfield microscopy.READ MORE
Back in 2009, researchers identified a herd of Awassi sheep suffering from "day blindness". As that term implies, these sheep were blind during the day (in bright light) but could see at night, in low-light conditions. After identifying the genetic basis of this blindness, researchers have now successfully used gene therapy to restore their daytime vision.READ MORE